Primary Mediastinal Large B-Cell Lymphoma

Primary Mediastinal Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 33
Ph III recruiting: 0
Growth YoY: —
Industry share: 24%
Top sponsor: University of Washington
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05228249	Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma	withdrawn	Phase 1	0	Fred Hutchinson Cancer CenterOTHER	1	Jan 13, 2023	clinicaltrials
NCT02706405	JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma	terminated	Phase 1	30	Fred Hutchinson Cancer CenterOTHER	1	Aug 24, 2022